NanoTx

THERAPEUTICS

 

NanoTx has reached an agreement with Plus Therapeutics for the licensing and development of Rhenium Nanoliposomes:

Plus Therapeutics Website


PREVIOUS NEWS:

NanoTx has received a New Company award notice from the Cancer Prevention and Research Institute of Texas (CPRIT). Please see CPRIT's website here.


The first in human study for RNL is now underway:

Medical ​Xpress Article





Please check back periodically for additional news as the study progresses....